Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Germany”

Threshold Concentrations for Ragweed and Birch Pollen in Seasonal Allergic RhinitisCompleted
NCT05346718NAUpdated Jul 24, 2026
Sponsor: Fraunhofer-Institute of Toxicology and Experimental Medicine
Allergic Rhinitis · Seasonal Allergic Rhinitis · Ragweed Allergy · Birch Pollen Allergy
Germany
MB-CART19.1 r/r CD19+ B-cell Malignancies (BCM)Active Not Recruiting
NCT03853616Phase 1Updated Jul 24, 2026
Sponsor: Miltenyi Biomedicine GmbH
Acute Lymphoblastic Leukemia Recurrent · B-cell Lymphoma Recurrent · B-cell Lymphoma Refractory · Chronic Lymphocytic Leukemia Recurrent
Germany
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung CancerRecruiting
NCT06712355Phase 3Updated Jul 24, 2026
Sponsor: BioNTech SE
Extensive-stage Small-cell Lung Cancer
United States, Australia, China, France, Germany +9 more
A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin AnalogsRecruiting
NCT06930625Phase 3Updated Jul 24, 2026
Sponsor: Debiopharm International SA
Acromegaly
United States, Austria, Belgium, Brazil, Bulgaria +16 more
A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of GM1 Gangliosidosis or GM2 GangliosidosisActive Not Recruiting
NCT07082543Phase 3Updated Jul 24, 2026
Sponsor: Azafaros B.V.
Gangliosidoses, GM2 · Gangliosidosis, GM1
United States, Argentina, Australia, Brazil, Canada +9 more
Efficacy, Safety and Tolerability of Givinostat in Non-ambulant Patients With Duchenne Muscular DystrophyRecruiting
NCT05933057Phase 3Updated Jul 24, 2026
Sponsor: Italfarmaco
Duchenne Muscular Dystrophy
Belgium, Canada, Czechia, France, Germany +7 more
Evaluating DFPP for Microplastic and PFAS ReductionEnrolling By Invitation
NCT07658443N/AUpdated Jul 24, 2026
Sponsor: Proxima Health, Inc.
Microplastic and Nanoplastic Particle Burden in Peripheral Blood · Double-Filtration Plasmapheresis
Germany, Switzerland
A Study in Adults to Learn About Inherited Alpha-1 Antitrypsin Deficiency (AATD) and AATD Related Liver ProblemsRecruiting
NCT06512454N/AUpdated Jul 24, 2026
Sponsor: Takeda
Alpha1-Antitrypsin Deficiency
United States, Austria, Germany, Ireland, Spain +1 more
Development of a Novel Non-invasive Inflammometry Following Allergen Challenge in Patients With Mild Allergic AsthmaRecruiting
NCT06317909NAUpdated Jul 24, 2026
Sponsor: Fraunhofer-Institute of Toxicology and Experimental Medicine
Mild Allergic Asthma
Germany
Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)Recruiting
NCT05722938Phase 3Updated Jul 24, 2026
Sponsor: Biotest
Community-acquired Pneumonia
United States, Argentina, Australia, Austria, Belgium +13 more
A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.Completed
NCT05523167Phase 2, Phase 3Updated Jul 24, 2026
Sponsor: argenx
Active Idiopathic Inflammatory Myopathy · Myositis · Dermatomyositis · Polymyositis
United States, Argentina, Australia, Austria, Belgium +31 more
Roll-over Study for Patients Who Have Completed a Prior Novartis-sponsored Sabatolimab (MBG453) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Sabatolimab.Active Not Recruiting
NCT05201066Phase 2Updated Jul 24, 2026
Sponsor: Novartis Pharmaceuticals
Myelodysplastic Syndromes · Leukemia, Myelomonocytic, Chronic
United States, Australia, Brazil, Canada, China +10 more
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma ExacerbationsActive Not Recruiting
NCT06052267Phase 3Updated Jul 24, 2026
Sponsor: Teva Branded Pharmaceutical Products R&D LLC
Asthma
United States, Argentina, Australia, Bulgaria, Canada +17 more
CD19-B Cell Depletion in PAIS-ME/CFS PatientsNot Yet Recruiting
NCT07724834Phase 2Updated Jul 24, 2026
Sponsor: Charite University, Berlin, Germany
Post-acute Infectious Syndrome (PAIS) · Post-COVID 19 Condition (PCC or Long COVID) · Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Germany
A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)Recruiting
NCT07680764Phase 2Updated Jul 24, 2026
Sponsor: Bristol-Myers Squibb
Locally Advanced Non-Small Cell Lung Cancer (NSCLC) · Metastatic Non-Small Cell Lung Cancer (NSCLC)
United States, Argentina, Australia, Brazil, Chile +7 more
The Effect of Physiotherapy Integrated With Yoga and Mindfulness on Individuals With FibromyalgiaCompleted
NCT07145788NAUpdated Jul 24, 2026
Sponsor: University Hospital Tuebingen
Fibromyalgia (FM) · Chronic Pain
Germany
To Assess the Correlation of High-resolution Specimen PET-CT Imaging, Using the XEOS AURA 10 PET-CT, With the Histopathology Results and Long-term Outcome of Patients Undergoing Resective Cancer Surgery.Recruiting
NCT06970275N/AUpdated Jul 24, 2026
Sponsor: XEOS Medical
Prostate Cancers · Breast Cancer · Head and Neck Cancer · Cancer
Belgium, Germany, Netherlands, United Kingdom
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)Active Not Recruiting
NCT04548999Phase 3Updated Jul 24, 2026
Sponsor: Hoffmann-La Roche
Multiple Sclerosis
United States, Argentina, Belgium, Brazil, Bulgaria +17 more
L19IL2/L19TNF in Patients With Cutaneous Squamous Cell CarcinomaRecruiting
NCT07228442Phase 2Updated Jul 24, 2026
Sponsor: Philogen S.p.A.
Locally Advanced Cutaneous Squamous Cell Carcinoma
United States, Germany, Greece, Italy, Spain
Avacostar - (PASS)Active Not Recruiting
NCT05897684N/AUpdated Jul 24, 2026
Sponsor: Vifor Fresenius Medical Care Renal Pharma
ANCA-associated Vasculitis
Germany, United Kingdom
An Observational Study to Assess the Effectiveness and Safety of a Cemiplimab in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) in Routine Clinical Practice Settings in EuropeRecruiting
NCT05363319N/AUpdated Jul 24, 2026
Sponsor: Regeneron Pharmaceuticals
Non-small Cell Lung Cancer
Austria, France, Germany, Italy, Spain
NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer.Active Not Recruiting
NCT06379217Phase 1Updated Jul 24, 2026
Sponsor: Novartis Pharmaceuticals
Metastatic Neuroendocrine Prostate Cancer
United States, France, Germany, Spain, United Kingdom
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or ObesityRecruiting
NCT07037433Phase 3Updated Jul 24, 2026
Sponsor: Amgen
Atherosclerotic Cardiovascular Disease · Overweight · Obesity
United States, Argentina, Australia, Austria, Belgium +31 more
A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD) and HyperinflationRecruiting
NCT07073950Phase 4Updated Jul 24, 2026
Sponsor: AstraZeneca
Chronic Obstructive Pulmonary Disease · Hyperinflation
Germany, United Kingdom
Adherence to Medication in Patients With Acute Decompensated Heart FailureCompleted
NCT06459115N/AUpdated Jul 24, 2026
Sponsor: Universität des Saarlandes
Acute Decompensated Heart Failure
Germany

Previous page Next page